Protein Kinase Inhibitors: all 15,766 studies that test it

Page 152 of 158. Open to participants first (2,605), then studies with results posted, then the rest; newest registration first within each.

• Imatinib Mesylate and Capecitabine in Treating Patients With Advanced Solid TumorsCompletedNCT00253565Phase 1
• Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast CancerCompletedNCT00253539Phase 2
• RAD001 Plus Docetaxel in Patients With Metastatic Breast CancerTerminatedNCT00253318Phase 1
• A Study of ZD1839 Effects on Cell Proliferation in Breast CancerWithdrawnNCT00252811Phase 2
• ZD6474 Phase IIa Dose Finding Multicentre StudyCompletedNCT00252746Phase 2
• Use of Sirolimus vs. Tacrolimus For African-American Renal Transplant RecipientsStatus unknownNCT00252655Phase 4
• GW572016 With Docetaxel and Trastuzumab for the Treatment Of Untreated ErbB2 Over-Expressing Metastatic Breast CancerTerminatedNCT00251433Phase 1
• A Phase II Study of Gleevec and Arsenic Trioxide in Patients With CML Who Fail GleevecCompletedNCT00250042Phase 2
• A Study of MLN8054 in Patients With Advanced Solid TumorsTerminatedNCT00249301Phase 1
• Imatinib Mesylate After Irinotecan and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00248482Phase 2
• Study Comparing Cyclosporin Dose Reduction With Cyclosporin Elimination in Kidney Transplant Recipients Taking SirolimusCompletedNCT00248313Phase 3
• Use of Curcumin in the Lower Gastrointestinal Tract in Familial Adenomatous Polyposis PatientsWithdrawnNCT00248053Phase 2
• The Efficacy of Coenzyme Q10 And Curcumin in Patients With Myelodysplastic SyndromesWithdrawnNCT00247026Phase 1/2
• Phase II Gemcitabine + Cisplatin +/- Iressa Bladder CCTCompletedNCT00246974Phase 2
• Paclitaxel + Carboplatin With/Out Cediranib Maleate in Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00245154Phase 2/3
• Tipifarnib and Sorafenib Tosylate in Treating Patients With Biopsiable Advanced CancerCompletedNCT00244972Phase 1
• Imatinib Mesylate After a Donor Stem Cell Transplant in Treating Patients With Philadelphia Chromosome-Positive LeukemiaCompletedNCT00244829Phase 1/2
• Pilot Study Using Neoadj Chemo-Rad & EGFR-tyrosine Kinase Inhibitor for Potentially Resectable Pancreatic CancerCompletedNCT00243854Phase 1
• TKI258 in Subjects With Refractory or Relapsed Multiple MyelomaTerminatedNCT00243763Phase 1
• Investigation of Safety, Tolerability and Maximum Tolerated Dose (MTD) of BI 2536 in Patients With Recurrent Advanced Aggressive Non-Hodgkin's Lymphoma (NHL)CompletedNCT00243087Phase 1
• Safety and Effectiveness Study of Docetaxel and ZD1839 Followed by Removal of the Prostate to Treat Prostate CancerCompletedNCT00242918Phase 2
• Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple MyelomaTerminatedNCT00242827Phase 2
• Iressa vs Best Supportive Care - 2nd/3rd Line Survival StudyCompletedNCT00242801Phase 3
• IRESSA™ In Combo With Xeloda™ in Advanced Colorectal Cancer Patients After 1st-Line Chemo FailureCompletedNCT00242788Phase 1/2
• ZD1839 (IRESSA™) in Combination With Docetaxel & Cisplatin in Subjects With Metastatic Head & Neck CancerCompletedNCT00242762Phase 2
• IRESSA in Combination With Cisplatin & Radiotherapy in Patients With Advanced Head & Neck CarcinomaCompletedNCT00242749Phase 2
• Gefitinib in the Treatment of the First Relapse of Prostate Cancer Beyond Prostatectomy or RadiotherapyCompletedNCT00241475Phase 2
• Rapamycin vs Methotrexate in Diffuse SScCompletedNCT00241189Phase 1/2
• Phase II Trial of Preoperative Therapy With Gefitinib and Chemotherapy in Patients With ERneg Breast CancerCompletedNCT00239343Phase 2
• Gefitinib (Iressa) in Combo With Chemoradiation in Patients With Locally Advanced Head & Neck CancerCompletedNCT00239304Phase 1/2
• Safety Study to Explore Combination of Gefitinib (ZD1839, Iressa) and Radiotherapy in Non-Metastatic Prostate CancerCompletedNCT00239291Phase 1/2
• Lapatinib (GW572016) for Metastatic or Recurrent Squamous Cell Carcinoma EsophagusTerminatedNCT00239200Phase 2
• A Phase II Exploratory, Multicentre, Open-label, Non-comparative Study of ZD1839 (Iressa) and Radiotherapy in the Treatment of Patients With Glioblastoma MultiformeCompletedNCT00238797Phase 2
• A Phase I/II Study of Bexarotene in Combination With ZD1839 (IRESSA®) in the Treatment of Non-Small Cell Lung CancerCompletedNCT00238628Phase 1/2
• Cediranib Maleate in Treating Patients With Locally Advanced or Metastatic Liver CancerCompletedNCT00238394Phase 2
• Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain MetastasesCompletedNCT00238251Phase 2
• S0514 Sorafenib in Treating Patients With Unresectable or Metastatic Gallbladder Cancer or CholangiocarcinomaCompletedNCT00238212Phase 2
• Gefitinib in Combination With Chemoradiation in Resectable Gastric CancerTerminatedNCT00237900Phase 1/2
• Phase II Clinical Study of Imatinib Mesylate in Patients With Malignant Gastrointestinal Stromal Tumors (Extension Study)CompletedNCT00237172Phase 2
• Efficacy, Safety and Long-term Prognosis of Imatinib in Patients Newly Diagnosed With Chronic Myelogenous Leukemia (Chronic Phase)CompletedNCT00237120Phase 3
• Study of the Efficacy, Safety and Tolerability of Oral CEP-701 in Patients With Severe PsoriasisCompletedNCT00236119Phase 2
• An Open Label Exploratory Study in Newly Diagnosed Prostate Cancer PatientsCompletedNCT00235794Not applicable
• Rapamycin in Combination With Low-dose Aracytin in Elderly Acute Myeloid Leukemia PatientsCompletedNCT00235560Phase 2
• Safety Study of XL844 in Subjects With Chronic Lymphocytic LeukemiaTerminatedNCT00234481Phase 1
• Iressa vs Placebo as Maintenance Therapy in Locally Advanced NSCLCTerminatedNCT00234468Phase 3
• Iressa in the Treatment of Brain Metastases From Non Small Cell Lung CancerTerminatedNCT00234442Phase 2
• A Phase 2 Study of Tomudex & Iressa as Second Line Chemotherapy in Subjects With Colorectal CarcinomaCompletedNCT00234429Phase 2/3
• A Trial to Evaluate the Combination of Iressa & Faslodex® in Patients With Advanced or Metastatic Breast CancerCompletedNCT00234403Phase 2
• Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and NeckWithdrawnNCT00233636Phase 2
• Irinotecan, 5-Fluorouracil and Leucovorin With or Without Iressa in the Treatment of Metastatic Colorectal CancerWithdrawnNCT00233623Phase 2
• PROACT - Pre-Operative Arimidex Compared To TamoxifenCompletedNCT00232661Phase 3
• Phase II Gleevec Idiopathic Hypereosinophilic SyndromeTerminatedNCT00230334Phase 2
• Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa StudyCompletedNCT00229697Phase 2
• Effect of Iressa With/Without Concurrent Chemoradiotherapy on Tumor Gene Expression Profiles in Patients With Advanced Non-Nasopharyngeal Head and Neck CarcinomaCompletedNCT00228488Phase 2
• Study Evaluating CCI-779 in Relapsing Multiple SclerosisCompletedNCT00228397Phase 2
• Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine TumorsWithdrawnNCT00227773Phase 2
• Erlotinib in Treating Patients With Progressive Glioblastoma MultiformeTerminatedNCT00227032Phase 1
• PTK787 in Patients With Advanced Metastatic Pancreatic AdenocarcinomaCompletedNCT00226005Phase 2
• Study To Evaluate The Safety, Pharmacokinetics, And Pharmacodynamics Of PF-00299804 In Patients With Advanced Solid TumorsCompletedNCT00225121Phase 1
• Maribavir for Prevention of CMV After Stem Cell TransplantsCompletedNCT00223925Phase 2
• Study of Gleevec and Taxotere in Recurrent Non-Small Cell Lung CancerCompletedNCT00222144Phase 2
• Safety and Efficacy of Imatinib in Combination With High Dose Chemotherapy for Acute Phase Chronic Myelogenous PatientsTerminatedNCT00219765Phase 1/2
• Safety and Efficacy of Imatinib in Chronic Myelogenous Patients Older Than 70 YearsCompletedNCT00219752Phase 2
• STI571 ProspectIve RandomIzed Trial: SPIRITCompletedNCT00219739Phase 3
• Safety and Efficacy of Imatinib in Chronic Myelogenous Patients in Relapse After Stem Cell TransplantationCompletedNCT00219726Phase 2
• Gefitinib as First-Line Therapy Followed by Gemcitabine and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00217698Phase 2
• Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous LeukemiaCompletedNCT00217646Phase 1
• Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube CancerCompletedNCT00217529Phase 1/2
• Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian CancerCompletedNCT00216112Phase 2
• PTK787 + Trastuzumab for HER2 Overexpressing Metastatic Breast CancerTerminatedNCT00216047Phase 1/2
• Cisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric CarcinomasCompletedNCT00215995Phase 2
• Study of the Safety, Tolerability and Pharmacokinetics of 1 Mg/Eye and 3 Mg/Eye Pegaptanib Sodium in Patients With Exudative Age-Related Macular Degeneration (AMD)CompletedNCT00215670Phase 2/3
• Study of XL184 (Cabozantinib) in Adults With Advanced MalignanciesCompletedNCT00215605Phase 1
• Phase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC)CompletedNCT00215202Phase 2
• Tamoxifen Therapy in Amyotrophic Lateral Sclerosis [ALS]CompletedNCT00214110Phase 2
• A Study Of Nasopharyngeal Carcinoma (NPC) Treated With Celecoxib And ZD1839CompletedNCT00212108Phase 1/2
• Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast CancerTerminatedNCT00210028Phase 2
• Phase II Trial of Gleevec and Taxotere as a Combined Regimen for Advanced Gastric AdenocarcinomaTerminatedNCT00209079Phase 2
• MAD in Cancer Patients: Safety of BMS-582664 in Patients With Advanced or Metastatic Solid TumorsCompletedNCT00207103Phase 1
• Study of Cetuximab in Combination With Tarceva in Patients With Solid TumorsCompletedNCT00207077Phase 1
• BMS-582664 in Combination With Erbitux in Patients With Advanced Gastrointestinal MalignanciesCompletedNCT00207051Phase 1
• MAD Refractory: Solid Tumor QD w/o BreakCompletedNCT00207012Phase 1
• Anti-Estrogens - A Potential Treatment for Bipolar Affective Disorder in Women?CompletedNCT00206544Phase 2
• Trial of ZD1839 (Iressa) and Tamoxifen in Breast Cancer PatientsTerminatedNCT00206492Phase 2
• Arimidex/Faslodex/Iressa Study: A Trial Using Arimidex, Faslodex and Iressa in Women With Breast CancerTerminatedNCT00206414Phase 2
• Influence of Sirolimus and MMF on Vascular Function and Markers of Cellular Function in Renal Transplant RecipientsCompletedNCT00204321Phase 4
• OSI-774 (Erlotinib, Tarceva) in Elderly PatientsCompletedNCT00200395Phase 2
• Study Comparing Imatinib With Chemotherapy as Induction in Elderly Patients With Philadelphia Positive Acute Lymphoblastic Leukemia (ALL)Status unknownNCT00199186Phase 2
• Efficacy and Activity of BAY 43-9006 in Patients With Recurrent and/or Metastatic Head and Neck CancerCompletedNCT00199160Phase 2
• Randomized Phase 2 Study of 3 Therapeutic Modalities in PS 2/3 Patients With NSCLC Stage IIIB/IVCompletedNCT00198393Phase 2
• Treatment of Lung Adenocarcinoma With Bronchioloalveolar FeatureCompletedNCT00198380Phase 2
• A Phase II Study of Iressa in Patients With Chemo Refractory Germ Cell Tumors Expressing EGFRTerminatedNCT00198159Phase 2
• Study Evaluating Sirolimus in Kidney Transplant Recipients in IndiaCompletedNCT00195481Phase 4
• Safety Trial of IRESSA, Cisplatin and Radiation Therapy for Patients With Head and Neck CancerTerminatedNCT00195078Phase 1/2
• Bevacizumab and Erlotinib in the Treatment of Patients With Carcinoma of Unknown Primary SiteCompletedNCT00193622Phase 2
• Iressa in Poor Performance Status Patients With Previously Untreated Advanced Non-Small Cell Lung CancerCompletedNCT00193336Phase 2
• Chemotherapy Plus Gefitinib Followed by Chemotherapy, Radiation Therapy, and Gefitinib For Head and Neck CancerCompletedNCT00193284Phase 2
• OSI-774 and Bevacizumab in the Treatment of Patients With Metastatic Renal Cell CarcinomaCompletedNCT00193154Phase 2
• Gemcitabine With Curcumin for Pancreatic CancerCompletedNCT00192842Phase 2
• The Effect of Ruboxistaurin on Small Fiber FunctionCompletedNCT00190970Phase 2

← Protein Kinase Inhibitors overview